Tanya Laidlaw, MD

My research and clinical expertise is focused on patients with chronic rhinosinusitis with nasal polyps, severe asthma, and aspirin-exacerbated respiratory disease (AERD). My laboratory’s efforts are aimed at understanding the causative mechanisms for these diseases and exploring new treatments for patients with respiratory inflammation. We have been particularly interested in the inflammatory role of mast cells, platelets, eicosanoids, and the dysregulation of pathways of Type 2 immunity, with a translational approach that includes ongoing studies that span in vitro cellular and molecular experiments through Phase 3 clinical trials.